Head-To-Head Comparison of Vortioxetine Versus Desvenlafaxine in Patients With Major Depressive Disorder With Partial Response to SSRI Therapy
The Journal of Clinical Psychiatry · 2023
DOI: 10.4088/jcp.23m14780 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift The Journal of Clinical Psychiatry, 2023. Verfasst von Roger S McIntyre und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Major Depressive Disorder, Serotonin and Noradrenaline Reuptake Inhibitors. Die Arbeit wurde bisher 25-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.
- Brain and Cognition Discovery Foundation, Toronto, Ontario, Canada.
- H. Lundbeck A/S, Valby, Denmark.
- Corresponding author: Michael Cronquist Christensen, H. Lundbeck A/S, Ottiliavej 9, 2500 Valby, Denmark (MCRC@lundbeck.com).
Zitieren
APA
McIntyre, R. S., Florea, I., Pedersen, M. M., & Christensen, M. C. (2023). Head-To-Head Comparison of Vortioxetine Versus Desvenlafaxine in Patients With Major Depressive Disorder With Partial Response to SSRI Therapy. The Journal of Clinical Psychiatry. https://doi.org/10.4088/jcp.23m14780
Vancouver
McIntyre RS, Florea I, Pedersen MM, Christensen MC. Head-To-Head Comparison of Vortioxetine Versus Desvenlafaxine in Patients With Major Depressive Disorder With Partial Response to SSRI Therapy. The Journal of Clinical Psychiatry. 2023. doi:10.4088/jcp.23m14780
BibTeX
@article{McIntyre2023,
author = {McIntyre, Roger S and Florea, Ioana and Pedersen, Mads Møller and Christensen, Michael Cronquist},
title = {Head-To-Head Comparison of Vortioxetine Versus Desvenlafaxine in Patients With Major Depressive Disorder With Partial Response to SSRI Therapy},
journal = {The Journal of Clinical Psychiatry},
year = {2023},
doi = {10.4088/jcp.23m14780}
}
EUVIMED